LOOK MY GREEN POINT AT RSI AND ON CHART ..
novavax technically is giving a good entry with stop loss if the news get well it well touch the sky like follow and share if it was usefull
Yesterday's close was positive +2% as we wanted to hold the support and uptrend . today we continue for the same scenario we want whatever possitive close again. My first pt if we have good news is 300usd.
This proved to the market and world governments that their nanotechnology is superior and that it works. Next stop, flu vaccine. I'm holding. Disclaimer: Not financial advice. Just my opinion. See my related posts. Source: www.cnn.com
Moderna is the first company to start the phase 3 trial in July and could have the supply ready earliest by Oct and accelerated approval earliest by December, according to Nami Sumida/BioPharma Dive and morningstar. Other competitors are scheduled to have accelerated approval the earliest around early 2021.
Preliminary studies on coronavirus vaccines have produced promising results. I'm still a believer in their technology. Check out my previous NVAX posts and/or the first one. They have a promising technology that could revolutionize the vaccine industry. We (humanity) are already very behind in how we produce vaccines AKA using chicken eggs. So Novavax will...
I still believe NVAX has a lot of potential and I'll say it again. My idea is clear that its NanoParticle and Matrix-M Adjuvant tech makes it a prime candidate for a COVID-19 vaccines. Even if it doesn't make it first (or ever), it still has major potential for the seasonal influenza (w/ NanoFlu) and its Respiratory Syncytial Virus (RSV) vaccine. Check out my...
These are my thoughts on Novavax. They are meant to give you an idea, not trading advice. As written in the textbooks, gaps in a downtrend always get filled in an uptrend. We already filled gap 1. I believe it's time to start filling gap 2, witch is gigantic. Novavax is receiving a lot of financial support for making a Covid19 vaccin, so expectations are high for...
I've been following NVAX since price was at $12. Fundamentally they have one of the most promising COVID vaccines and their Nano Flu shot beat Sanify's flu shot, whos been a market majority holder in that aspect. Technically, we've tapped that $150+ zone 8 out of the last 9 fast rises over since the company IPO'd in 1996. Each of the rises have been driven by...
Just re-iterating my previous assertion (guess) that NVAX is on course for massive gains in the long-term. Doesn't mean it's a great company but this pandemic has initiated a similar pattern in the past. They have several great developments in the works: NanoFlu, RSV F, and a COVID-19 vaccine candidate. See my previous posts especially the related one. This is...
All description on the chart. Please, don't forget to like and follow. Thank you.
Technical Analysis - Check/wait if one of the supports will not be broken before buying On a daily chart there might be a Bottom Saucer or Rounding Reversal Pattern Fundamental News: Novavax (NASDAQ:NVAX) is a clinical-stage biotechnology company focused on the discovery, development and commercialisation of vaccines and adjuvants. Through its recombinant...
I'm bull-ish on Novavax (see Related Idea). I think their approach to the COVID-19 vaccine is promising - their recombinant nanoparticle vaccine technology and Matrix-M adjuvant. They also have positive long-term prospects with their proprietary NanoFlu candidate. This is the big one to me. It's unclear whether COVID-19 becomes seasonal or not but influenza is...
#Novavax hit the weekly 100SMA and stalling and forming double top. It may pull back on next week.
I am a little late publishing this chart, I entered the trade on Friday. NVAX has strong support at around $1.96 and has bounced there several times. My target is $2.34 and depending on how strong NVAX looks I may just take a partial there and trail my stop behind the rest.
Pretty reasonable target for a retracement, with stop loss just below the range support. Small possibility of double bottoming at 1.17 too! so be prepared for it. Oct 21th $1.5 CALLS